A/AT variety/NN of/IN techniques/NNS have/HV been/BEN directed/VBN toward/IN the/AT isolation/NN and/CC study/NN of/IN blood/NN group/NN antibodies/NNS ./pct
These/DTS include/VB low-temperature/NN ethanol/NN (/pct Cohn/NP )/pct fractionation/NN ,/pct electrophoresis/NN ,/pct ultracentrifugation/NN and/CC column/NN chromatography/NN on/IN ion/NN exchange/NN celluloses/NNS ./pct
Modifications/NNS of/IN the/AT last/AP technique/NN have/HV been/BEN applied/VBN by/IN several/AP groups/NNS of/IN investigators/NNS ./pct
Abelson/NP and/CC Rawson/NP ,/pct using/VBG a/AT stepwise/JJ elution/NN scheme/NN ,/pct fractionated/VBD whole/JJ sera/NNS containing/VBG ABO/NN and/CC Rh/NN antibodies/NNS on/IN diethylaminoethyl/NN DEAE/NN cellulose/NN and/CC carboxymethyl/NN cellulose/NN ./pct
Speer/NP and/CC coworkers/NNS ,/pct in/IN a/AT similar/JJ study/NN of/IN blood/NN group/NN antibodies/NNS of/IN whole/JJ sera/NNS ,/pct used/VBD a/AT series/NN of/IN gradients/NNS for/IN elution/NN from/IN Aj/NN ./pct
Fahey/NP and/CC Morrison/NP used/VBD a/AT single/AP ,/pct continuous/JJ gradient/NN at/IN constant/JJ pH/NN for/IN the/AT fractionation/NN of/IN anti-A/JJ and/CC anti-B/JJ agglutinins/NNS from/IN preisolated/VBN **yg-globulin/NN samples/NNS ./pct
In/IN the/AT present/JJ work/NN whole/JJ sera/NNS have/HV been/BEN fractionated/VBN by/IN chromatography/NN on/IN DEAE-cellulose/NN using/VBG single/AP gradients/NNS similar/JJ to/IN those/DTS described/VBN by/IN Sober/NP and/CC Peterson/NP ,/pct and/CC certain/AP chemical/JJ and/CC serological/JJ properties/NNS of/IN the/AT fractions/NNS containing/VBG antibodies/NNS of/IN the/AT ABO/NN and/CC Rh/NN systems/NNS have/HV been/BEN described/VBN ./pct
Materials/NNS and/CC methods/NNS
samples/NNS ./pct
Serum/NN samples/NNS were/BED obtained/VBN from/IN normal/JJ group/NN A/NN ,/pct group/NN B/NN and/CC group/NN O/NN donors/NNS ./pct
Three/CD of/IN the/AT anti-Rh/JJ sera/NNS used/VBN were/BED taken/VBN from/IN recently/RB sensitized/VBN individuals/NNS ./pct
One/CD contained/VBD complete/JJ antibody/NN and/CC had/HVD a/AT titer/NN of/IN 1/CD :/pct 512/CD in/IN saline/NN ./pct
The/AT second/OD contained/VBD incomplete/JJ antibody/NN and/CC showed/VBD titers/NNS of/IN 1/CD :/pct 256/CD in/IN albumin/NN and/CC 1/CD :/pct 2048/CD by/IN the/AT indirect/JJ Coombs/NP test/NN ./pct
The/AT third/OD ,/pct containing/VBG the/AT mixed/VBN type/NN of/IN complete/JJ and/CC incomplete/JJ antibodies/NNS ,/pct had/HVD titers/NNS of/IN 1/CD :/pct 256/CD in/IN saline/NN ,/pct 1/CD :/pct 512/CD in/IN albumin/NN and/CC 1/CD :/pct 1024/CD by/IN the/AT indirect/JJ Coombs/NP test/NN ./pct
In/IN addition/NN one/CD serum/NN was/BEDZ obtained/VBN from/IN a/AT donor/NN (/pct R./NP E./NP )/pct who/WPS had/HVD been/BEN sensitized/VBN 6/CD years/NNS previously/RB ./pct
This/DT serum/NN exhibited/VBD titers/NNS of/IN 1/CD :/pct 16/CD in/IN albumin/NN and/CC 1/CD :/pct 256/CD by/IN the/AT indirect/JJ Coombs/NP test/NN ./pct
These/DTS antibody/NN titers/NNS were/BED determined/VBN by/IN reaction/NN with/IN homozygous/JJ Af/NN red/JJ cells/NNS ./pct
Serological/JJ technique/NN ./pct
Anti-A/JJ and/CC anti-B/JJ activities/NNS were/BED determined/VBN in/IN fractions/NNS from/IN the/AT sera/NNS of/IN group/NN A/NN ,/pct group/NN B/NN or/CC group/NN O/NN donors/NNS by/IN the/AT following/VBG tube/NN agglutination/NN methods/NNS ./pct
One/CD drop/NN of/IN each/DT sample/NN was/BEDZ added/VBN to/IN one/CD drop/NN of/IN a/AT 2%/NN suspension/NN of/IN group/NN Af/NN or/CC group/NN B/NN red/JJ cells/NNS in/IN a/AT small/JJ Af/NN test/NN tube/NN ./pct
In/IN several/AP instances/NNS group/VB O/NN cells/NNS were/BED also/RB used/VBN as/CS controls/NNS ./pct
The/AT red/JJ cells/NNS were/BED used/VBN within/IN 2/CD days/NNS after/IN donation/NN and/CC were/BED washed/VBN with/IN large/JJ amounts/VBZ of/IN saline/NN before/IN use/NN ./pct
The/AT mixtures/NNS of/IN sample/NN plus/IN cell/NN suspension/NN were/BED allowed/VBN to/TO stand/VB at/IN room/NN temperature/NN for/IN 1/CD Aj/NN ./pct
The/AT tubes/NNS were/BED then/RB centrifuged/VBN at/IN 1000/CD rpm/NN for/IN 1/CD min/NN and/CC examined/VBN macroscopically/RB for/IN agglutination/NN ./pct
For/IN the/AT albumin/NN method/NN ,/pct equal/JJ volumes/NNS of/IN 30%/NN bovine/NN albumin/NN ,/pct sample/NN and/CC 2%/NN cells/NNS suspended/VBN in/IN saline/NN were/BED allowed/VBN to/TO stand/VB at/IN room/NN temperature/NN for/IN 1/CD hr/NN and/CC then/RB were/BED centrifuged/VBN at/IN 1000/CD rpm/NN for/IN 1/CD Aj/NN ./pct
All/ABN samples/NNS were/BED tested/VBN by/IN both/ABX the/AT saline/NN and/CC albumin/NN methods/NNS ./pct
The/AT activities/NNS of/IN fractions/NNS of/IN sera/NNS containing/VBG Rh/NN antibodies/NNS were/BED tested/VBN by/IN the/AT saline/NN ,/pct albumin/NN and/CC indirect/JJ Coombs/NP techniques/NNS ./pct
Homozygous/JJ and/CC heterozygous/JJ Af/NN cells/NNS ,/pct Af/NN and/CC homozygous/JJ and/CC heterozygous/JJ Af/NN cells/NNS were/BED used/VBN to/TO test/VB each/DT sample/NN ;/pct ;/pct
however/RB ,/pct in/IN the/AT interest/NN of/IN clarity/NN and/CC conciseness/NN only/RB the/AT results/NNS obtained/VBN with/IN homozygous/JJ Af/NN and/CC homozygous/JJ Af/NN cells/NNS will/MD be/BE presented/VBN here/RB ./pct
The/AT saline/NN and/CC albumin/NN tests/NNS were/BED performed/VBN as/CS described/VBN for/IN the/AT ABO/NN samples/NNS except/IN that/CS the/AT mixture/NN was/BEDZ incubated/VBN for/IN 1/CD hr/NN at/IN 37-degrees-C/NNS before/IN centrifugation/NN ./pct
The/AT saline/NN tubes/NNS were/BED saved/VBN and/CC used/VBN for/IN the/AT indirect/JJ Coombs/NP test/NN in/IN the/AT following/VBG manner/NN ./pct
The/AT cells/NNS were/BED washed/VBN three/CD times/NNS with/IN saline/NN ,/pct anti-human/JJ serum/NN was/BEDZ added/VBN ,/pct the/AT cells/NNS were/BED resuspended/VBN ,/pct and/CC the/AT mixture/NN was/BEDZ centrifuged/VBN at/IN 1000/CD rpm/NN for/IN 1/CD min/NN and/CC examined/VBN for/IN agglutination/NN ./pct
The/AT anti-human/JJ sera/NNS used/VBN were/BED prepared/VBN by/IN injecting/VBG whole/JJ human/JJ serum/NN into/IN rabbits/NNS ./pct
Those/DTS antisera/NNS shown/VBN by/IN immunoelectrophoresis/NN to/TO be/BE of/IN the/AT ``/pct broad/JJ spectrum/NN ''/pct type/NN were/BED selected/VBN for/IN use/NN in/IN the/AT present/JJ study/NN ./pct
The/AT red/JJ cells/NNS for/IN the/AT Rh/NN antibody/NN tests/NNS were/BED used/VBN within/IN 3/CD days/NNS after/IN drawing/VBG except/IN for/IN the/AT Af/NN cells/NNS ,/pct which/WDT had/HVD been/BEN glycerolized/VBN and/CC stored/VBN at/IN -20-degrees-C/NNS for/IN approximately/RB 1/CD year/NN ./pct
These/DTS cells/NNS were/BED thawed/VBN at/IN 37-degrees-C/NNS for/IN 30/CD min/NN and/CC were/BED deglycerolized/VBN by/IN alternately/RB centrifuging/VBG and/CC mixing/VBG with/IN descending/VBG concentrations/NNS of/IN glycerol/NN solutions/NNS (/pct 20/CD ,/pct 18/CD ,/pct 10/CD ,/pct 8/CD ,/pct 4/CD and/CC 2%/NN )/pct ./pct
The/AT cells/NNS were/BED then/RB washed/VBN three/CD times/NNS with/IN saline/NN and/CC resuspended/VBN to/IN 2%/NN in/IN saline/NN ./pct
Chromatography/NN ./pct
Blood/NN samples/NNS were/BED allowed/VBN to/TO clot/VB at/IN room/NN temperature/NN for/IN 3/CD hr/NN ,/pct centrifuged/VBN and/CC the/AT serum/NN was/BEDZ removed/VBN ./pct
The/AT serum/NN was/BEDZ measured/VBN volumetrically/RB and/CC subsequently/RB dialyzed/VBN in/IN the/AT cold/JJ for/IN at/IN least/AP 24/CD hr/NN against/IN three/CD to/IN four/CD changes/NNS ,/pct approximately/RB 750/CD ml/NN each/DT ,/pct of/IN ``/pct starting/VBG buffer/NN ''/pct ./pct
This/DT buffer/NN ,/pct pH/NN 8.6/CD ,/pct was/BEDZ 0.005/CD M/NN in/IN Af/NN and/CC 0.039/CD M/NN in/IN tris(hydroxymethyl)-aminometha/NN (/pct Tris/NP )/pct ./pct
After/IN dialysis/NN the/AT sample/NN was/BEDZ centrifuged/VBN and/CC the/AT supernatant/NN placed/VBN on/IN a/AT Af/NN cm/NN column/NN of/IN EEAE-cellulose/NN equilibrated/VBN with/IN starting/VBG buffer/NN ./pct
The/AT DEAE-cellulose/NN ,/pct containing/VBG 0.78/CD mEq/NN of/IN N:g/NN ,/pct was/BEDZ prepared/VBN in/IN our/PPg laboratory/NN by/IN the/AT method/NN of/IN Peterson/NP and/CC Sober/NP (/pct 7/CD )/pct from/IN powdered/VBN cellulose/NN ,/pct 100/CD -/pct 230/CD mesh/NN ./pct
The/AT small/JJ amount/NN of/IN insoluble/JJ material/NN which/WDT precipitated/VBD during/IN dialysis/NN was/BEDZ suspended/VBN in/IN approximately/RB 5/CD ml/NN of/IN starting/VBG buffer/NN ,/pct centrifuged/VBN ,/pct resuspended/VBN in/IN 2.5/CD ml/NN of/IN isotonic/JJ saline/NN and/CC tested/VBN for/IN antibody/NN activity/NN ./pct
The/AT chromatography/NN was/BEDZ done/VBN at/IN 6-degrees-C/NNS using/VBG gradient/NN elution/NN ,/pct essentially/RB according/IN to/IN Sober/NP and/CC Peterson/NP ./pct
The/AT deep/JJ concave/JJ gradient/NN employed/VBN (/pct fig./NN 2/CD )/pct was/BEDZ obtained/VBN with/IN a/AT nine-chambered/JJ gradient/NN elution/NN device/NN (/pct ``/pct Varigrad/NP ''/pct ,/pct reference/NN (/pct 8/CD )/pct )/pct and/CC has/HVZ been/BEN described/VBN elsewhere/RB ./pct
The/AT other/AP ,/pct a/AT shallow/JJ concave/JJ gradient/NN (/pct Fig./NN 1/CD )/pct ,/pct was/BEDZ produced/VBN with/IN a/AT so-called/JJ ``/pct cone-sphere/NN ''/pct apparatus/NN ,/pct the/AT ``/pct cone/NN ''/pct being/BEG a/AT 2-liter/JJ Erlenmeyer/NP flask/NN and/CC the/AT ``/pct sphere/NN ,/pct ''/pct a/AT 2-liter/JJ round-bottom/NN flask/NN ./pct
Each/DT initially/RB contained/VBD 1700/CD ml/NN of/IN buffer/NN ;/pct ;/pct
in/IN the/AT sphere/NN was/BEDZ starting/VBG buffer/NN and/CC in/IN the/AT cone/NN was/BEDZ final/JJ buffer/NN ,/pct 0.50/CD M/NN in/IN both/ABX Af/NN and/CC Tris/NP ,/pct pH/NN 4.1/CD ./pct
A/AT flow/NN rate/NN of/IN 72/CD Af/NN was/BEDZ used/VBN and/CC 12/CD ml/NN fractions/NNS were/BED collected/VBN ./pct
Approximately/RB 165/CD fractions/NNS were/BED obtained/VBN from/IN each/DT column/NN ./pct
These/DTS were/BED read/VBN at/IN 280/CD m**ym/NN in/IN a/AT Beckman/NP model/NN DU/NN spectrophotometer/NN and/CC tested/VBN for/IN antibody/NN activity/NN as/CS described/VBN above/RB ./pct
Paper/NN electrophoresis/NN ./pct
For/IN protein/NN identification/NN ,/pct fractions/NNS from/IN the/AT column/NN were/BED concentrated/VBN by/IN pervaporation/NN against/IN a/AT stream/NN of/IN air/NN at/IN 5-degrees-C/NNS or/CC by/IN negative/JJ pressure/NN dialysis/NN in/IN an/AT apparatus/NN which/WDT permitted/VBD simultaneous/JJ concentration/NN of/IN the/AT protein/NN and/CC dialysis/NN against/IN isotonic/JJ saline/NN ./pct
During/IN the/AT latter/AP procedure/NN the/AT temperature/NN was/BEDZ maintained/VBN at/IN 2-degrees-C/NNS by/IN surrounding/VBG the/AT apparatus/NN with/IN ice/NN ./pct
Because/CS negative/JJ pressure/NN dialysis/NN gave/VBD better/JJR recovery/NN of/IN proteins/NNS ,/pct permitted/VBD detection/NN of/IN proteins/NNS concentrated/VBN from/IN very/QL dilute/JJ solutions/NNS and/CC was/BEDZ a/AT gentler/JJR procedure/NN ,/pct it/PPS was/BEDZ used/VBN in/IN all/ABN but/IN the/AT earliest/JJT experiments/NNS ./pct
Paper/NN electrophoresis/NN was/BEDZ carried/VBN out/RP on/IN the/AT concentrated/VBN samples/NNS in/IN a/AT Spinco/NP model/NN R/NN cell/NN using/VBG barbital/NN buffer/NN ,/pct pH/NN 8.6/CD ,/pct ionic/JJ strength/NN 0.075/CD ,/pct at/IN room/NN temperature/NN on/IN Whatman/NP 3MM/NN filter/NN paper/NN ./pct
Five/CD milliamperes:cell/NNS were/BED applied/VBN for/IN 18/CD hr/NN ,/pct after/IN which/WDT the/AT strips/NNS were/BED stained/VBN with/IN bromphenol/NN blue/NN and/CC densitometry/NN was/BEDZ carried/VBN out/RP using/VBG a/AT Spinco/NP Analytrol/NP ./pct
When/WRB paper/NN electrophoresis/NN was/BEDZ to/TO be/BE used/VBN for/IN preparation/NN ,/pct eight/CD strips/NNS of/IN a/AT whole/JJ serum/NN sample/NN or/CC a/AT chromatographic/JJ fraction/NN concentrated/VBN by/IN negative/JJ pressure/NN dialysis/NN were/BED run:chamber/VBN under/IN the/AT conditions/NNS described/VBN above/RB ./pct
At/IN the/AT end/NN of/IN the/AT run/NN ,/pct the/AT strips/NNS in/IN the/AT third/OD and/CC sixth/OD positions/NNS in/IN each/DT chamber/NN were/BED dried/VBN ,/pct stained/VBN for/IN 1/CD hr/NN ,/pct washed/VBN and/CC dried/VBN ,/pct while/CS the/AT other/AP strips/NNS were/BED maintained/VBN in/IN a/AT horizontal/JJ position/NN at/IN 1-degree-C/NN ./pct
The/AT unstained/JJ strips/NNS were/BED then/RB marked/VBN ,/pct using/VBG the/AT stained/VBN ones/NNS as/CS a/AT guide/NN ,/pct and/CC cut/VBN transversely/RB so/CS as/CS to/TO separate/VB the/AT various/JJ protein/NN bands/NNS ./pct
The/AT strip/NN sections/NNS containing/VBG a/AT given/VBN protein/NN were/BED pooled/VBN ,/pct eluted/VBN with/IN 0.5/CD ml/NN of/IN isotonic/JJ saline/NN ,/pct and/CC the/AT eluates/NNS were/BED tested/VBN for/IN antibody/NN activity/NN ./pct
Ultracentrifugation/NN ./pct
Fractions/NNS from/IN the/AT column/NN which/WDT were/BED to/TO be/BE subjected/VBN to/IN analytical/JJ ultracentrifugation/NN were/BED concentrated/VBN by/IN negative/JJ pressure/NN dialysis/NN and/CC dialyzed/VBN for/IN 16/CD hr/NN in/IN the/AT cold/NN against/IN at/IN least/AP 500/CD volumes/NNS of/IN phosphate-buffered/JJ saline/NN ,/pct pH/NN 7.2/CD ,/pct ionic/JJ strength/NN 0.154/CD ./pct
They/PPSS were/BED then/RB centrifuged/VBN at/IN 59,780/CD Pm/NN for/IN 35/CD to/IN 80/CD min/NN at/IN 20-degrees-C/NNS in/IN a/AT Spinco/NP model/NN E/NN ultracentrifuge/NN at/IN a/AT protein/NN concentration/NN of/IN 1.00/CD to/IN 1.25%/NN ./pct
Sedimentation/NN coefficients/NNS were/BED computed/VBN as/CS Af/NN values/NNS and/CC relative/JJ amounts/NNS of/IN the/AT various/JJ components/NNS were/BED calculated/VBN from/IN the/AT Schlieren/NP patterns/NNS ./pct
For/IN preparative/JJ ultracentrifugation/NN ,/pct fractions/NNS from/IN the/AT column/NN were/BED concentrated/VBN by/IN negative/JJ pressure/NN dialysis/NN to/IN volumes/NNS of/IN 1/CD ml/NN or/CC less/AP ,/pct transferred/VBN to/IN cellulose/NN tubes/NNS and/CC diluted/VBN to/IN 12/CD ml/NN with/IN isotonic/JJ saline/NN ./pct
Ultracentrifugation/NN was/BEDZ then/RB carried/VBN out/RP in/IN a/AT Spinco/NP model/NN L/NN ultracentrifuge/NN at/IN 40,000/CD rpm/NN for/IN 125/CD to/IN 150/CD min/NN ,/pct refrigeration/NN being/BEG used/VBN throughout/IN the/AT run/NN ./pct
Successive/JJ 1-ml/NN fractions/NNS were/BED then/RB drawn/VBN off/RP with/IN a/AT hypodermic/JJ syringe/NN ,/pct starting/VBG at/IN the/AT top/NN of/IN the/AT tube/NN ,/pct and/CC tested/VBN for/IN agglutinin/NN activity/NN ./pct
Other/AP methods/NNS will/MD be/BE described/VBN below/RB ./pct
Experimental/JJ and/CC results/NNS
The/AT insoluble/JJ material/NN which/WDT precipitated/VBD during/IN dialysis/NN against/IN starting/VBG buffer/NN always/RB showed/VBD intense/JJ agglutinin/NN activity/NN ,/pct regardless/RB of/IN the/AT blood/NN group/NN of/IN the/AT donor/NN ./pct
With/IN either/DTX of/IN the/AT gradients/NNS described/VBN ,/pct chromatography/NN on/IN DEAE-cellulose/NN separated/VBN agglutinins/NNS of/IN the/AT ABO/NN series/NN into/IN at/IN least/AP three/CD regions/NNS (/pct Figs./NNS 1/CD and/CC 2/CD )/pct :/pct one/CD of/IN extremely/QL low/JJ anionic/JJ binding/NN capacity/NN ,/pct one/CD of/IN low/JJ anionic/JJ binding/NN capacity/NN and/CC one/CD of/IN high/JJ anionic/JJ binding/NN capacity/NN ./pct
These/DTS have/HV been/BEN labeled/VBN Regions/NNS 1/CD ,/pct 2/CD ,/pct and/CC 4/CD ,/pct respectively/RB ,/pct in/IN Fig./NN 1/CD ./pct
When/WRB the/AT early/JJ part/NN of/IN the/AT gradient/NN was/BEDZ flattened/VBN ,/pct either/CC by/IN using/VBG the/AT gradient/NN shown/VBN in/IN Fig./NN 2/CD or/CC by/IN allowing/VBG the/AT ``/pct cone-sphere/NN ''/pct gradient/NN to/TO become/VB established/VBN more/QL slowly/RB ,/pct Region/NN 2/CD activity/NN could/MD sometimes/RB be/BE separated/VBN into/IN two/CD areas/NNS (/pct donors/NNS P./NP J./NP and/CC R./NP S./NP ,/pct Fig./NN 1/CD and/CC E./NP M./NP ,/pct Fig./NN 2/CD )/pct ./pct
The/AT latter/AP procedure/NN gave/VBD rise/NN to/IN a/AT small/JJ active/JJ protein/NN peak/NN (/pct Region/NN 1a/CD )/pct between/IN Regions/NNS 1/CD and/CC 2/CD ./pct
In/IN 2/CD of/IN 15/CD experiments/NNS on/IN whole/JJ serum/NN a/AT region/NN of/IN agglutinin/NN activity/NN with/IN intermediate/JJ anionic/JJ binding/NN capacity/NN was/BEDZ detected/VBN (/pct Region/NN 3/CD ,/pct Fig./NN 1/CD )/pct ./pct
Moreover/RB ,/pct after/IN concentration/NN using/VBG negative/JJ pressure/NN dialysis/NN ,/pct agglutinin/NN activity/NN could/MD sometimes/RB be/BE detected/VBN in/IN the/AT region/NN designated/VBN 2a/CD (/pct donors/NNS P./NP J./NP ,/pct D./NP A./NP ,/pct and/CC J./NP F./NP ,/pct Fig./NN 1/CD )/pct ./pct
Not/NEG all/ABN these/DTS regions/NNS exhibited/VBD equal/JJ agglutinating/VBG activity/NN ,/pct as/CS evidenced/VBN by/IN titer/NN and/CC the/AT extent/NN of/IN the/AT active/JJ areas/NNS ./pct
In/IN all/ABN cases/NNS ,/pct most/AP of/IN the/AT activity/NN lay/VBD in/IN the/AT region/NN of/IN high/JJ anionic/JJ binding/NN capacity/NN ./pct
This/DT was/BEDZ particularly/QL noticeable/JJ in/IN group/NN A/NN and/CC group/NN B/NN sera/NNS ,/pct in/IN which/WDT cases/NNS activity/NN in/IN Regions/NNS 1/CD and/CC 2/CD was/BEDZ usually/RB not/NEG detectable/JJ without/IN prior/JJ concentration/NN and/CC occasionally/RB could/MD not/NEG be/BE detected/VBN at/IN all/ABN ./pct
There/EX appeared/VBD to/TO be/BE no/AT difference/NN in/IN the/AT distribution/NN of/IN anti-A/JJ and/CC anti-B/JJ activity/NN in/IN group/NN O/NN serum/NN ,/pct though/CS in/IN two/CD group/NN O/NN donors/NNS (/pct J./NP F./NP and/CC E./NP M./NP )/pct only/RB one/CD type/NN of/IN agglutinin/NN was/BEDZ found/VBN in/IN the/AT regions/NNS of/IN low/JJ anionic/JJ binding/NN capacity/NN (/pct Figs./NNS 1/CD and/CC 2/CD )/pct ./pct
Several/AP samples/NNS of/IN citrated/JJ plasma/NN were/BED fractionated/VBN in/IN our/PPg laboratory/NN by/IN Method/NN 6/CD of/IN Cohn/NP et/CC al/NNS ./pct
These/DTS fractions/NNS were/BED tested/VBN for/IN ABO/NN agglutinin/NN activity/NN ,/pct using/VBG fractions/NNS from/IN group/NN AB/NN plasma/NN as/CS a/AT control/NN ./pct
As/CS expected/VBN ,/pct most/AP of/IN the/AT activity/NN was/BEDZ found/VBN in/IN Fraction/NN Af/NN ,/pct with/IN slight/JJ activity/NN seen/VBN in/IN Fraction/NN 4-1/CD ./pct
A/AT sample/NN of/IN Fraction/NN Af/NN from/IN group/NN O/NN plasma/NN was/BEDZ dissolved/VBN in/IN starting/VBG buffer/NN ,/pct dialyzed/VBN against/IN this/DT buffer/NN and/CC subjected/VBN to/IN chromatography/NN using/VBG the/AT gradient/NN shown/VBN in/IN Fig./NN 2/CD ./pct
Once/RB again/RB ,/pct both/ABX anti-A/JJ and/CC anti-B/JJ activities/NNS were/BED found/VBN in/IN the/AT insoluble/JJ material/NN precipitated/VBN during/IN dialysis/NN ./pct
Similarly/RB ,/pct both/ABX types/NNS of/IN antibodies/NNS were/BED found/VBN in/IN three/CD regions/NNS of/IN the/AT chromatographic/JJ eluate/NN ,/pct having/HVG extremely/QL low/JJ ,/pct low/JJ ,/pct and/CC high/JJ anionic/JJ binding/NN capacity/NN ,/pct respectively/RB (/pct Fig./NN 3/CD )/pct ./pct
Chromatography/NN of/IN whole/JJ sera/NNS revealed/VBD that/CS the/AT areas/NNS of/IN Rh/NN antibody/NN activity/NN were/BED generally/RB continuous/JJ and/CC wide/JJ ./pct
The/AT incomplete/JJ antibody/NN activity/NN appeared/VBD in/IN the/AT early/JJ part/NN of/IN the/AT chromatogram/NN ;/pct ;/pct
the/AT complete/JJ ,/pct in/IN the/AT latter/AP part/NN ./pct
The/AT serum/NN containing/VBG the/AT mixed/VBN type/NN of/IN complete/JJ and/CC incomplete/JJ antibodies/NNS showed/VBD activity/NN in/IN both/ABX regions/NNS (/pct Fig./NN 1/CD )/pct ./pct
In/IN all/ABN cases/NNS the/AT activity/NN against/IN Af/NN cells/NNS was/BEDZ spread/VBN over/IN a/AT wider/JJR area/NN than/CS that/DT with/IN Af/NN cells/NNS ,/pct regardless/RB of/IN the/AT type/NN of/IN test/NN (/pct saline/NN ,/pct albumin/NN ,/pct indirect/JJ Coombs/NP )/pct used/VBN for/IN comparison/NN ./pct
The/AT insoluble/JJ material/NN resulting/VBG from/IN dialysis/NN against/IN starting/VBG buffer/NN always/RB showed/VBD strong/JJ activity/NN ./pct
In/IN fact/NN agglutination/NN of/IN Af/NN cells/NNS in/IN saline/NN could/MD be/BE produced/VBN by/IN the/AT insoluble/JJ material/NN from/IN sera/NNS containing/VBG ``/pct only/AP ''/pct incomplete/JJ antibody/NN activity/NN ./pct
This/DT was/BEDZ later/RBR known/VBN to/TO be/BE the/AT result/NN of/IN concentrating/VBG the/AT minute/JJ amount/NN of/IN complete/JJ antibody/NN found/VBN in/IN these/DTS sera/NNS ;/pct ;/pct
when/WRB the/AT insoluble/JJ fraction/NN was/BEDZ suspended/VBN in/IN a/AT volume/NN of/IN saline/NN equal/JJ to/IN that/DT of/IN the/AT original/JJ serum/NN sample/NN ,/pct no/AT complete/JJ antibody/NN activity/NN could/MD be/BE detected/VBN ./pct
